Halozyme Therapeutics (HALO) Prepaid Assets (2010 - 2026)

Halozyme Therapeutics (HALO) has 17 years of Prepaid Assets data on file, last reported at $121.9 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 21.6% year-over-year to $121.9 million in Q1 2026; TTM through Mar 2026 was $121.9 million, a 21.6% increase from a year earlier, with the FY2025 full-year figure at $64.6 million, up 65.95% from the prior year.
• Prepaid Assets for Q1 2026 stood at $121.9 million, up from $64.6 million in the prior quarter.
• Over the last five years, Prepaid Assets for HALO reached as high as $150.7 million in Q3 2025 and fell as low as $37.0 million in Q1 2023.
• Historically, Prepaid Assets has averaged $73.6 million across 5 years, with a median of $63.1 million in 2022.
• Across the five-year window, Prepaid Assets slumped 41.32% in 2023 and jumped 149.94% in 2024, its largest moves.
• Year by year, Prepaid Assets stood at $71.3 million in 2022, then slumped by 31.84% to $48.6 million in 2023, then decreased by 19.88% to $39.0 million in 2024, then jumped by 65.95% to $64.6 million in 2025, then soared by 88.54% to $121.9 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $121.9 million in Q1 2026, $64.6 million in Q4 2025, and $150.7 million in Q3 2025.